BackHaemonetics Overview

Haemonetics Accounts Payable

Track Haemonetics's accounts payable ($56M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$56.34M
22.45% YoYΔ $10.33M vs prior year quarter

Peer trimmed avg / median

Loading

Haemonetics Accounts Payable History

Loading

Haemonetics vs. peers: Accounts Payable Comparison

Loading

Haemonetics Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Haemonetics (HAE) FAQ

As of the most recent data (June 2026), HAE shows a accounts payable of $56M. That compares with $46M in the prior-year period — up 22.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HAE's accounts payable is now $56M (was $46M) — a 22.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Haemonetics is outperforming or lagging.

Tracking HAE's accounts payable over time shows whether Haemonetics is scaling, shrinking, or reshaping that part of the business. The current reading is $56M That compares with $46M in the prior-year period — up 22.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Haemonetics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $56M) with ownership activity and broader fundamentals.

Haemonetics's accounts payable is $56M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.